Levit, Elle Bouley, Andrew Baber, Ursela Djonlagic, Ina Sloane, Jacob A.
Background: Studies linking MRI findings in MS patients with obstructive sleep apnea severity are limited. Objective: We conducted a retrospective study to assess MRI abnormalities associated with obstructive sleep apnea (OSA) in patients with multiple sclerosis (MS). Methods: We performed retrospective chart review of 65 patients with multiple scl...
Gummalla, Sangeetha Manjunath, Madhura Phillips, Brian
The advent of immune checkpoint inhibitors has significantly improved the prognosis of patients with advanced malignancies. As we begin to understand these medications, multiple immune-related adverse effects (irAEs) have been found with these drugs, including endocrinopathies. Understanding the treatment-related adverse events of these medications...
Nwosu, Benjamin U. Villalobos-Ortiz, Tony R. Jasmin, Gabrielle Parajuli, Sadichchha Zitek-Morrison, Emily Barton, Bruce A.
Objectives: The is no consensus on the early patterns of lipid-based cardiovascular disease (CVD) risk in youth with either type 1 diabetes (T1D) or type 2 diabetes (T2D). The aim was to determine the differences in CVD risk, using lipid profiles, in children and adolescents with either T1D or T2D at the time of their first lipid assessment, after ...
Kay, Jonathan Harigai, Masayoshi Rancourt, Josh Dickson, Christina Melby, Thomas Issa, Maher de la Torre, Inmaculada Isaka, Yoshitaka Cardoso, Anabela Saifan, Chadi
...
OBJECTIVE: To characterise changes in selected haematological parameters following once-daily oral baricitinib dosing. METHODS: Data were pooled from eight randomised clinical trials (four phase 3, three phase 2, one phase 1b) and one long-term extension. Changes in haematological parameters were evaluated up to 128 weeks (N=2387); overall safety o...
Kiritsy, Michael C.
The breadth of genetic diversity in the mammalian immune response stands out amongst the ubiquity of variation seen in the genome, evidence that microbial infections have been a major driver of evolution. As technology has facilitated an understanding of the etiology of immunological diversity, so too has it enabled the assessment of its varied fun...
Sahu, Kamal Kant Borogovac, Azra Cerny, Jan
The current pandemic due to coronavirus disease (COVID-19) has posed an unprecedented challenge for the medical communities, various countries worldwide and their citizens. SARS-CoV-2 has been studied for its various pathophysiological pathways and mechanisms through which it causes COVID-19. In this study, we discussed the immunological impact of ...
Harrold, Leslie R. Shan, Ying Rebello, Sabrina Kramer, Neil Connolly, Sean E. Alemao, Evo Kelly, Sheila Kremer, Joel M. Rosenstein, Elliot D.
The objective of this study was to compare rheumatoid arthritis (RA) disease activity and patient-reported outcomes (PROs) in a national sample of patients with RA with/without Sjogren's syndrome (SS). Adults with RA from a large observational US registry (Corrona RA) with known SS status between 22 April 2010 and 31 July 2018 and a visit 12 (+/- 3...
Cai, Erica P. Ishikawa, Yuki Zhang, Wei Leite, Nayara C. Li, Jian Hou, Shurong Kiaf, Badr Hollister-Lock, Jennifer Yilmaz, Nese Kurt Schiffer, Celia A.
...
Type 1 diabetes (T1D) is caused by the autoimmune destruction of pancreatic beta cells. Pluripotent stem cells can now be differentiated into beta cells, thus raising the prospect of a cell replacement therapy for T1D. However, autoimmunity would rapidly destroy newly transplanted beta cells. Using a genome-scale CRISPR screen in a mouse model for ...
Sahu, Kamal Kant Siddiqui, Ahmad Daniyal Rezaei, Nima Cerny, Jan
It is almost six months since novel Coronavirus disease 2019 (COVID-19) started as a local outbreak in Wuhan, China(1) For hematologists and patients suffering from hematological disorders, the COVID-19 pandemic has brought challenges with regards to the diagnosis, treatment, follow-up, office visits, and so on. (2,3) We hereby discuss the current ...
Garelli, Colton J. Ahmed Refat, Maggi Nanaware, Padma P. Ramirez-Ortiz, Zaida G. Rashighi, Medhi Richmond, Jillian M.
Cutaneous Lupus Erythematosus (CLE) is a clinically diverse group of autoimmune skin diseases with shared histological features of interface dermatitis and autoantibodies deposited at the dermal-epidermal junction. Various genetic and environmental triggers of CLE promote infiltration of T cells, B cells, neutrophils, antigen presenting cells, and ...